Market Cap ₹784 Cr.
Stock P/E 21.2
P/B 2.6
Current Price ₹1307.2
Book Value ₹ 509.5
Face Value 10
52W High ₹1599
Dividend Yield 1.91%
52W Low ₹ 800
Empire Industries Ltd is engaged in manufacturing and advertising and marketing operations that cover the area of system tools, business equipment, vending, meals, real estate and glass containers for prescribed drugs. The Company's segments consist of Manufacturing, which includes production glass bottles; Trading, Business Support Service, Consultancy and Commission, and Others. Its geographical segments consist of Domestic and International. It is also engaged in the production of Amber Glass Bottles for the pharmaceutical industry; representing various overseas manufacturers of precision device gear, measuring gadgets, testing machines, designing and advertising and marketing of industrial equipment; importing frozen and chilled foods and distributing it to accommodations and restaurant; supplying office area on leave and license foundation to multinational organizations and banks; developing land admeasuring to approximately 30 acres at Ambernath, and presenting customizable work space solutions to clients.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 148 | 184 | 172 | 178 | 148 | 154 | 153 | 152 | 152 | 163 |
Other Income | 2 | 2 | 6 | 4 | 2 | 3 | 15 | 5 | 3 | 4 |
Total Income | 150 | 186 | 178 | 182 | 150 | 156 | 168 | 157 | 155 | 167 |
Total Expenditure | 132 | 165 | 156 | 151 | 132 | 135 | 146 | 129 | 135 | 144 |
Operating Profit | 18 | 22 | 22 | 31 | 18 | 22 | 22 | 28 | 19 | 23 |
Interest | 7 | 8 | 7 | 11 | 6 | 8 | 5 | 8 | 5 | 7 |
Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 7 | 9 | 10 | 16 | 8 | 10 | 12 | 15 | 11 | 11 |
Provision for Tax | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 1 | 2 |
Profit After Tax | 6 | 8 | 8 | 14 | 6 | 8 | 10 | 13 | 10 | 10 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Profit After Adjustments | 6 | 8 | 8 | 14 | 6 | 8 | 10 | 13 | 10 | 10 |
Adjusted Earnings Per Share | 9.9 | 13 | 13.7 | 22.6 | 10.2 | 13.4 | 17 | 21 | 16.1 | 16.3 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 314 | 354 | 385 | 405 | 473 | 526 | 575 | 490 | 544 | 682 | 606 | 620 |
Other Income | 7 | 5 | 5 | 6 | 27 | 33 | 19 | 23 | 10 | 15 | 25 | 27 |
Total Income | 320 | 359 | 390 | 411 | 500 | 559 | 593 | 514 | 554 | 696 | 631 | 647 |
Total Expenditure | 254 | 291 | 324 | 338 | 411 | 467 | 500 | 447 | 485 | 603 | 542 | 554 |
Operating Profit | 67 | 68 | 66 | 73 | 89 | 91 | 93 | 67 | 69 | 93 | 89 | 92 |
Interest | 11 | 9 | 10 | 14 | 16 | 20 | 32 | 35 | 27 | 33 | 27 | 25 |
Depreciation | 8 | 12 | 10 | 9 | 13 | 11 | 15 | 19 | 15 | 17 | 16 | 16 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -6 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 48 | 46 | 47 | 50 | 60 | 61 | 40 | 13 | 28 | 43 | 46 | 49 |
Provision for Tax | 11 | 12 | 16 | 16 | 13 | 17 | 6 | -1 | 4 | 7 | 9 | 8 |
Profit After Tax | 36 | 34 | 31 | 34 | 47 | 44 | 34 | 13 | 24 | 36 | 37 | 43 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 36 | 34 | 31 | 34 | 47 | 44 | 34 | 13 | 24 | 36 | 37 | 43 |
Adjusted Earnings Per Share | 60.4 | 56.9 | 51.1 | 56.8 | 77.8 | 73.1 | 57 | 22 | 39.5 | 59.2 | 61.7 | 70.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -11% | 7% | 3% | 7% |
Operating Profit CAGR | -4% | 10% | -0% | 3% |
PAT CAGR | 3% | 42% | -3% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 38% | 24% | 13% | 3% |
ROE Average | 13% | 12% | 11% | 18% |
ROCE Average | 16% | 15% | 14% | 19% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 120 | 137 | 150 | 183 | 212 | 237 | 234 | 247 | 256 | 283 | 300 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 41 | 43 | 66 | 69 | 92 | 120 | 162 | 135 | 136 | 104 | 59 |
Other Non-Current Liabilities | 72 | 86 | 90 | 147 | 93 | 114 | 154 | 120 | 127 | 132 | 118 |
Total Current Liabilities | 147 | 153 | 200 | 144 | 191 | 205 | 234 | 211 | 188 | 219 | 250 |
Total Liabilities | 380 | 419 | 506 | 544 | 587 | 677 | 784 | 713 | 707 | 740 | 727 |
Fixed Assets | 134 | 135 | 217 | 215 | 217 | 213 | 317 | 303 | 352 | 317 | 315 |
Other Non-Current Assets | 83 | 94 | 8 | 9 | 67 | 124 | 99 | 97 | 31 | 25 | 45 |
Total Current Assets | 162 | 190 | 280 | 320 | 303 | 341 | 369 | 313 | 324 | 398 | 367 |
Total Assets | 380 | 419 | 506 | 544 | 587 | 677 | 784 | 713 | 707 | 740 | 727 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 45 | 33 | 32 | 77 | 90 | 78 | 37 | 26 | 43 | 49 | 68 |
Cash Flow from Operating Activities | 8 | 40 | 34 | 48 | 20 | -13 | 40 | 103 | 53 | 79 | 75 |
Cash Flow from Investing Activities | -42 | -17 | -3 | -3 | -49 | -34 | -45 | -4 | -2 | 29 | -15 |
Cash Flow from Financing Activities | 22 | -23 | 13 | -24 | 17 | 5 | -5 | -82 | -45 | -89 | -52 |
Net Cash Inflow / Outflow | -12 | -1 | 44 | 21 | -12 | -41 | -11 | 17 | 6 | 19 | 7 |
Closing Cash & Cash Equivalent | 33 | 32 | 76 | 98 | 78 | 37 | 26 | 43 | 49 | 68 | 75 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 60.41 | 56.89 | 51.08 | 56.79 | 77.79 | 73.06 | 56.96 | 22.01 | 39.49 | 59.21 | 61.67 |
CEPS(Rs) | 74.01 | 77.61 | 67.23 | 71.72 | 98.68 | 90.85 | 81.93 | 53.76 | 63.92 | 87.81 | 89.12 |
DPS(Rs) | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Book NAV/Share(Rs) | 199.26 | 227.27 | 249.7 | 305.27 | 353.49 | 395.63 | 389.52 | 411.74 | 426.18 | 472.35 | 500.36 |
Core EBITDA Margin(%) | 18.51 | 17.18 | 15.4 | 13.01 | 13.05 | 11.18 | 12.97 | 8.82 | 10.84 | 11.52 | 10.58 |
EBIT Margin(%) | 18.07 | 15.15 | 14.21 | 12.38 | 16.03 | 15.35 | 12.5 | 9.7 | 10.05 | 11.14 | 11.95 |
Pre Tax Margin(%) | 14.75 | 12.6 | 11.77 | 9.74 | 12.61 | 11.61 | 7 | 2.59 | 5.08 | 6.27 | 7.54 |
PAT Margin (%) | 11.21 | 9.35 | 7.73 | 6.59 | 9.8 | 8.33 | 5.95 | 2.69 | 4.36 | 5.21 | 6.11 |
Cash Profit Margin (%) | 13.73 | 12.76 | 10.17 | 8.33 | 12.43 | 10.36 | 8.55 | 6.58 | 7.05 | 7.73 | 8.82 |
ROA(%) | 10.39 | 8.55 | 6.63 | 6.49 | 8.25 | 6.93 | 4.68 | 1.76 | 3.34 | 4.91 | 5.05 |
ROE(%) | 32.99 | 26.68 | 21.42 | 20.46 | 23.62 | 19.5 | 14.51 | 5.49 | 9.43 | 13.18 | 12.68 |
ROCE(%) | 30.63 | 24.57 | 21.69 | 21.25 | 21.59 | 18.85 | 14.53 | 9.47 | 11.45 | 16.33 | 15.87 |
Receivable days | 64.45 | 59.79 | 63.31 | 54.46 | 64.2 | 72.07 | 71.56 | 72.93 | 70.43 | 85.15 | 107.83 |
Inventory Days | 41.81 | 66 | 85.16 | 81.72 | 88.95 | 86.37 | 103.63 | 117.52 | 80.99 | 58.38 | 64.93 |
Payable days | 92.73 | 93.56 | 117.94 | 100.23 | 62.54 | 45.53 | 48.7 | 48.09 | 41.22 | 41.99 | 59.03 |
PER(x) | 8.04 | 29.8 | 31.12 | 30.55 | 24.55 | 12.46 | 8.9 | 28.65 | 15.15 | 10.32 | 14.46 |
Price/Book(x) | 2.44 | 7.46 | 6.37 | 5.68 | 5.4 | 2.3 | 1.3 | 1.53 | 1.4 | 1.29 | 1.78 |
Dividend Yield(%) | 4.94 | 1.42 | 1.51 | 1.44 | 1.31 | 2.75 | 4.93 | 3.96 | 4.18 | 4.09 | 2.8 |
EV/Net Sales(x) | 1.14 | 3.04 | 2.64 | 2.65 | 2.62 | 1.39 | 0.98 | 1.15 | 0.97 | 0.68 | 1.02 |
EV/Core EBITDA(x) | 5.35 | 15.91 | 15.38 | 14.7 | 13.97 | 7.98 | 6.06 | 8.43 | 7.61 | 4.97 | 6.92 |
Net Sales Growth(%) | 12.06 | 12.89 | 8.73 | 5.21 | 16.81 | 11.18 | 9.22 | -14.7 | 10.97 | 25.28 | -11.09 |
EBIT Growth(%) | 4.79 | -5.38 | 1.86 | 13.57 | 19.31 | 5.79 | -11.07 | -33.8 | 15.02 | 38.84 | -4.58 |
PAT Growth(%) | 3.17 | -5.82 | -10.21 | 11.17 | 36.99 | -6.08 | -22.03 | -61.35 | 79.39 | 49.93 | 4.16 |
EPS Growth(%) | 3.17 | -5.82 | -10.21 | 11.17 | 36.99 | -6.08 | -22.03 | -61.35 | 79.39 | 49.93 | 4.16 |
Debt/Equity(x) | 0.84 | 0.69 | 0.93 | 0.71 | 0.86 | 0.95 | 1.25 | 0.94 | 0.87 | 0.6 | 0.53 |
Current Ratio(x) | 1.1 | 1.24 | 1.4 | 2.21 | 1.59 | 1.66 | 1.58 | 1.48 | 1.72 | 1.81 | 1.47 |
Quick Ratio(x) | 0.75 | 0.71 | 0.88 | 1.34 | 1.03 | 0.96 | 0.8 | 0.85 | 1.15 | 1.31 | 1.04 |
Interest Cover(x) | 5.43 | 5.94 | 5.83 | 4.7 | 4.69 | 4.1 | 2.27 | 1.36 | 2.02 | 2.29 | 2.71 |
Total Debt/Mcap(x) | 0.34 | 0.09 | 0.15 | 0.12 | 0.16 | 0.41 | 0.96 | 0.61 | 0.62 | 0.46 | 0.3 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 72.55 | 72.55 | 72.55 | 72.55 | 72.55 | 72.55 | 72.55 | 72.55 | 72.55 | 72.55 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 12.1 | 10.44 | 8.94 | 8.55 | 7.48 | 6.45 | 6.38 | 6.38 | 6.37 | 5.96 |
Public | 15.35 | 17 | 18.51 | 18.89 | 19.96 | 20.99 | 21.07 | 21.07 | 21.07 | 21.49 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.07 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Public | 0.09 | 0.1 | 0.11 | 0.11 | 0.12 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About